EUVIMEDEUVIMED entdecken
Crossref

Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations

Carolina Echeverry iD, Analía Richeri, Jimena Fagetti, Gaby F Martínez, Federico Vignolo, Giselle Prunell, Leticia Cuñetti, Marcela Martínez Busi, Sandra Pérez, Verónica Sánchez de Medina, Carlos Ferreiro, Cecilia Scorza iD

Cannabis & Cannabinoid Research · 2024

DOI: 10.1089/can.2022.0289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, 2024. Verfasst von Carolina Echeverry und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Mecanismos de Neurodegeneración y Neuroprotección and Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay. Hauptthemen laut MEDLINE: Rotenone, Neuroprotective Agents, Cannabidiol, Cannabis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preclinical research supports the benefits of pharmaceutical cannabis-based extracts for treating different medical conditions (e.g., epilepsy); however, their neuroprotective potential has not been widely investigated. Materials and Methods: Using primary cultures of cerebellar granule cells, we evaluated the neuroprotective activity of Epifractan (EPI), a cannabis-based medicinal extract containing a high level of cannabidiol (CBD), components like terpenoids and flavonoids, trace levels of Δ9-tetrahydrocannabinol, and the acid form of CBD. We determined the ability of EPI to counteract the rotenone-induced neurotoxicity by analyzing cell viability and morphology of neurons and astrocytes by immunocytochemical assays. The effect of EPI was compared with XALEX, a plant-derived and highly purified CBD formulation (XAL), and pure CBD crystals (CBD).

Results

The results revealed that EPI induced a significant reduction in the rotenone-induced neurotoxicity in a wide range of concentrations without causing neurotoxicity per se . EPI showed a similar effect to XAL suggesting that no additive or synergistic interactions between individual substances present in EPI occurred. In contrast, CBD did show a different profile to EPI and XAL because a neurotoxic effect per se was observed at higher concentrations assayed. Medium-chain triglyceride oil used in EPI formulation could explain this difference.

Conclusion

Our data support a neuroprotective effect of EPI that may provide neuroprotection in different neurodegenerative processes. The results highlight the role of CBD as the active component of EPI but also support the need for an appropriate formulation to dilute pharmaceutical cannabis-based products that could be critical to avoid neurotoxicity at very high doses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RotenoneNeuroprotective AgentsCannabidiolCannabisCerebellumPlant ExtractsNeuronsCell SurvivalAnimalsCells, CulturedRats

Stichwörter der Autor:innen

Cannabis sativaEpifractanXALEXastrocytescannabidiolneurotoxicity

Substanzen

RotenoneNeuroprotective AgentsCannabidiolPlant Extracts

Autor:innen und Institutionen

  • Laboratorio de Mecanismos de Neurodegeneración y Neuroprotección and Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay.
  • Departamento de Neurofarmacología Experimental, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay.
  • Instituto de Nefrología y Urología, Montevideo, Uruguay.
  • Plataforma de Química Analítica, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay.
  • Phytoplant Research S.L., Cordoba, Spain.

ORCID-Profile: Carolina Echeverry, Cecilia Scorza

Zitieren

APA

Echeverry, C., Richeri, A., Fagetti, J., Martínez, G. F., Vignolo, F., Prunell, G., Cuñetti, L., Martínez Busi, M., Pérez, S., de Medina, V. S., Ferreiro, C., & Scorza, C. (2024). Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations. Cannabis & Cannabinoid Research. https://doi.org/10.1089/can.2022.0289

Vancouver

Echeverry C, Richeri A, Fagetti J, Martínez GF, Vignolo F, Prunell G, et al. Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations. Cannabis & Cannabinoid Research. 2024. doi:10.1089/can.2022.0289

BibTeX
@article{Echeverry2024,
  author = {Echeverry, Carolina and Richeri, Analía and Fagetti, Jimena and Martínez, Gaby F and Vignolo, Federico and Prunell, Giselle and Cuñetti, Leticia and Martínez Busi, Marcela and Pérez, Sandra and de Medina, Verónica Sánchez and Ferreiro, Carlos and Scorza, Cecilia},
  title = {Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations},
  journal = {Cannabis & Cannabinoid Research},
  year = {2024},
  doi = {10.1089/can.2022.0289}
}
Kostenlos starten →